Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
TECX · against 392 other Healthcare companies of similar size
Ranked #242 of 393 · scores higher than 12% of peers
Bars: peers in each 10-point band of the valuation score152 peers with a valuation score of 0–9, including TECX · Click a bar to see the companies
Mainly because of its EBITDA yield, earnings yield and free cash flow yield, which are weaker than most Healthcare peers.
| Metric | TECX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 379 reported | -24.1% | -0.3% | 16% | 30% | |
| EBITDA yieldHigher is better · 396 reported | -63.1% | 2.1% | 7% | 50% | |
| Free cash flow yieldHigher is better · 188 reported | -19.5% | -9.3% | 29% | 20% | |
| Book yieldHigher is better · 388 reported | 61.3% | 50.4% | 60% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 3.5B HKD (≈$451M) | 99 | 51 | |
| 1 | 2.9B HKD (≈$365M) | 99 | 84 | |
| 1 | 89.9B JPY (≈$611M) | 99 | 68 | |
| 1 | 3.1B HKD (≈$396M) | 99 | 61 | |
| 1 | 29.0B JPY (≈$197M) | 99 | 56 | |
| 242 | 303M USD | 8 | 27 | |
| 242 | 354M USD | 8 | 13 | |
| 242 | 467M USD | 8 | 44 | |
| 242 | 549M USD | 8 | 30 | |
| 242 | 371M USD | 8 | ||
| 242 | 394M USD | 8 | 37 | |
| 242 | 513M USD | 8 | 31 | |
| 242 | 289M USD | 8 | ||
| 242 | 522M USD | 8 | 12 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score